Hims & Hers Health, Inc. (HIMS)
Hims & Hers faces legal battles with Novo Nordisk over alleged copycat drugs, while also seeing significant short interest and analyst price target variations, amidst ongoing discussions about its GLP-1 offerings and potential regulatory actions.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth platform focused on health and wellness services.
Hims & Hers Health, Inc. uses the ticker $HIMS for trading. Listed in the Stocks category within the Consumer Defensive sectors.
Insights
- Hims & Hers Health, Inc. (HIMS) social dominance is up 2860.66% from the previous week.
- Hims & Hers Health, Inc. (HIMS) sentiment is up 14.81% from the previous week.
- Hims & Hers Health, Inc. (HIMS) creators is up 81.89% from the previous month.
- Hims & Hers Health, Inc. (HIMS) mentions is up 85.32% from the previous month.
Price: $16.30
Price 24-Hour Time-Series Raw Data
The stock is experiencing significant volatility and a potential rebound, driven by the launch of a lower-cost semaglutide pill and news of a potential partnership, despite recent EPS misses and cautious analyst ratings. The 'buy the dip' sentiment is emerging amidst 'FDA news' and legal threats from competitors.
24-Hour: 1.18% 7-Day: -17.13% 30-Day: -48.06%
1-Year High: $68.70 on 2025-02-19
1-Year Low: $15.80 on 2026-02-12
AltRank: [--]
AltRank 24-Hour Time-Series Raw Data
Hims & Hers Health, Inc. (HIMS) is currently AltRank #46 based on combined combined social and market metrics
Daily Average: [--]
[--] Week: [--] +29
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] +54
1-Year High: [-----] on 2025-03-06
1-Year Low: [--] on 2025-02-19
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +10
[--] Months: [--] +2
[--] Year: [--] no change
1-Year High: [--] on 2025-03-24
1-Year Low: [--] on 2025-08-06
Engagements: [-------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-------]
Daily Average: [---------]
[--] Week: [----------] -32%
[--] Month: [----------] +70%
[--] Months: [-----------] -27%
[--] Year: [-----------] +243%
1-Year High: [----------] on 2025-06-23
1-Year Low: [-------] on 2025-12-07
Engagements by network (24h): Instagram: [---] YouTube: [-----] TikTok: [-----] X: [-------] News: [--] Reddit: [---]
Mentions: [-----] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +28%
[--] Month: [------] +85%
[--] Months: [-------] -30%
[--] Year: [-------] +261%
1-Year High: [------] on 2025-06-25
1-Year Low: [---] on 2025-12-07
Mentions by network (24h): Instagram: [--] YouTube: [--] TikTok: [--] X: [-----] News: [--] Reddit: [--]
Creators: [-----] (24h)
Creators 24-Hour Time-Series Raw Data
[-----] unique social accounts have posts mentioning Hims & Hers Health, Inc. (HIMS) in the last [--] hours which is down 18% from [-----] in the previous [--] hours
Daily Average: [-----]
[--] Week: [-----] +24%
[--] Month: [-----] +82%
[--] Months: [------] -45%
[--] Year: [------] +334%
1-Year High: [-----] on 2025-06-27
1-Year Low: [---] on 2025-12-07
The most influential creators that mention Hims & Hers Health, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @DeepIceValue | [--] | [------] | [--] | [------] |
| @growthrapidly | [--] | [------] | [--] | [------] |
| @mind1nvestor | [--] | [------] | [--] | [------] |
| @Mr_Derivatives | [--] | [-------] | [--] | [------] |
| @edgaralandough | [--] | [------] | [--] | [------] |
| @insiderinvests | [--] | [------] | [--] | [------] |
| @danielisdizzy | [--] | [------] | [--] | [------] |
| @A_May_MD | [--] | [------] | [--] | [------] |
| @Investinc_Intel | [--] | [-----] | [--] | [------] |
| @StockStalkk | [--] | [---] | [--] | [------] |
Sentiment: 70%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 70%
Daily Average: 77%
[--] Week: 62% +8%
[--] Month: 65% -16%
[--] Months: 65% -7%
[--] Year: 65% -25%
1-Year High: 93% on 2026-01-03
1-Year Low: 48% on 2026-02-09
Most Supportive Themes:
- Growth Potential in New Verticals: (40%) Hims & Hers is expanding into new areas like weight loss and men's health, which investors see as a significant growth opportunity.
- Market Position and Innovation: (35%) The company is recognized for its strong market standing and innovative approach to disrupting the healthcare industry.
- Bullish Chart Signals: (25%) Technical analysis of HIMS's stock charts suggests positive trends and potential for upward movement.
Most Critical Themes:
- Regulatory and Competitive Concerns: (100%) Concerns exist regarding potential regulatory hurdles and the competitive landscape from other telehealth providers and large pharmaceutical companies.
Social Dominance: 0.23%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.23%
Daily Average: 0.443%
[--] Week: 26.50% +25.60%
[--] Month: 0.475% +0.212%
[--] Months: 0.475% +0.026%
[--] Year: 0.475% -0.233%
1-Year High: 1.40% on 2025-06-25
1-Year Low: 0.125% on 2025-12-07
Market Dominance: 0.00416%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00416%
Daily Average: 0%
1-Year High: 0.246% on 2025-03-31
1-Year Low: 0.00416% on 2026-02-15
Market Cap: $3,671,970,531
Market Cap 24-Hour Time-Series Raw Data
Current Value: $3,671,970,531
Daily Average: $9,780,310,862
[--] Week: $3,677,183,682 -12%
[--] Month: $3,710,670,778 -48%
[--] Months: $3,710,670,778 -62%
[--] Year: $3,710,670,778 -72%
1-Year High: $15,271,661,419 on 2025-02-19
1-Year Low: $3,596,846,521 on 2026-02-12
Top Hims & Hers Health, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"I didnt expect an $NBIS investor to be able to read an income statement but holy shit this is embarrassing $HIMS has nearly 80% gross margins. Calling this razor thin margins is laughable. You also dont seem to understand the companys business model. It should be obvious from its margin profile that $HIMS isnt just another reseller. $HIMS FUD is getting tiresome so lazy"
X Link @Agrippa_Inv 2026-02-16T08:15Z 25.1K followers, [----] engagements
"$HIMS and $DUOL might be the worst stocks that retail fell for"
X Link @midascabal 2026-02-16T07:37Z 18.8K followers, [----] engagements
"@mymixtapez You can laugh at this or you can pay attention. There's a massive cultural push toward health & weight loss right now. Celebrities are the billboards. $HIMS $NVO $LLY these companies are about to eat. Watch the signs. Invest accordingly"
X Link @MrGrantinvest 2026-02-16T06:12Z [--] followers, 17.9K engagements
"My extremely risky strategy of going all-in taught me one thingdont marry your stocks. I am very flexible which is why I sold $HIMS in October and went all in on $IREN given I think it provides a much better risk reward opportunity. To be honest I sold it before offering GLP1 then canceling this plan after the FDA letter which was followed by $NVO lawsuit. None of that was expected In addition to that Andrew behavior of endorsing the potential squeeze mid October was a disaster for the stock. https://x.com/thetechinvest/status/1975402785882447912s=46"
X Link @TheTechInvest 2026-02-16T03:52Z 55K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing